A recent study reveals that patients who come off new slimming jabs like Wegovy and Mounjaro tend to recover lost weight far faster than those who halt traditional diet and exercise programs.
Research printed in a major medical journal shows that while overweight people often shed substantial amounts of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month once they quit.
"Users buying such drugs must be cognizant of the potential of fast rebound weight gain when the treatment concludes," cautioned expert Dr. Susan Jebb.
This pace of regain means a return to original weight within about 18 months.
Analyzing Treatments
The analysis, which looked at 37 of studies involving over 9,000 of patients, contrasted the results of the injectable medications with other pills.
Researchers emphasize that individuals who shed pounds through dieting typically experience a more gradual weight regain—perhaps 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Doctors propose the mode of action of the jabs is key to understanding the amplified regain.
These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its endogenous hormone, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication means hunger is uncontrolled, making excessive eating a significant risk."
A Chronic Issue?
The NHS suggest the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Professionals say that, considering the significant potential of relapse, the treatment should be considered ongoing.
This view is reinforced by pharmaceutical companies, who state that the results "underscore the long-term character of excess weight," akin to managing conditions like diabetes.
Patient Testimonies
Individuals who have come off the medication report a sudden resurgence of hunger.
"I experienced a switch that goes on and you're instantly starving," said an individual.
The struggle is worsened if users have not developed sustainable dietary or behavioural modifications during treatment.
Significant Interest
Survey data show that millions of adults in the UK have used these injections in the last 12 months, with interest being substantial.
- Use is more common among women compared to males.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic solution and lasting health benefits hinges on ongoing lifestyle changes.
